Description
Currently, it is estimated that about 400 million people or non-alcoholic steatohepatitis (NASH) patients have come to Japan. Nonalcoholic steatohepatitis (NASH) chronic hepatitis, despite the liver cancer, chronic liver disease leading to cirrhosis, there is no effective treatment means including the current drug. There is also the current situation that is often poor treatment effect do the diet and exercise therapy on an outpatient basis. However, in recent years to take advantage of the smartphone be treated intervention by "putting the correct knowledge", "to put the correct habit" has been found to be effective.
In response to such a background, this application has been developed by a joint research of the cure-up and the University of Tokyo Hospital Gastroenterology Co., Ltd., is a non-alcoholic steatohepatitis (NASH) therapeutic applications.
This version, intended for patients with non-alcoholic steatohepatitis (NASH), are intended for clinical studies investigating the feasibility and efficacy of a mobile intervention. In medical institutions affiliated with this application, you will be issued a prescription code in order to use this app.
If you would like more information, please contact the following.
Website: https://cureapp.co.jp/
E-mail: [email protected]